68Ga-NOTA-UBI-29-41 as a PET tracer for detection of bacterial infection

Journal of Nuclear Medicine

Volumn 57, Issue 4, 2016, Pages 622-627

  Vilche, Mónica ^a   Reyes, Ana Laura ^a   Vasilskis, Elena ^a   Oliver, Patricia ^a   Balter, Henia ^a   Engler, Henry ^a  

^a Uruguayan Centre of Molecular Imaging   (Uruguay)

Author keywords

68Ga; Infection diagnosis; PET CT; UBI 29 41; Ubiquicidin derived peptide

Indexed keywords

NOTA UBIQUICIDIN GA 68; PLASMA PROTEIN; TRACER; UNCLASSIFIED DRUG; 68GA-NOTA-UBI-29-41; COORDINATION COMPOUND; PEPTIDE; PROTEIN BINDING; RADIOPHARMACEUTICAL AGENT;

AGAR MEDIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MALE; MOUSE; MUS MUSCULUS; NONHUMAN; PH MEASUREMENT; PLASMA CLEARANCE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN BINDING; RADIOCHEMISTRY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; URINARY EXCRETION; ANIMAL; BACTERIAL INFECTION; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MICROBIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SCINTISCANNING; SYNTHESIS; TISSUE DISTRIBUTION;

ADMINISTRATION, INTRAVENOUS; ANIMALS; BACTERIAL INFECTIONS; COORDINATION COMPLEXES; INFLAMMATION; ISOTOPE LABELING; MALE; MICE; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RADIOPHARMACEUTICALS; STAPHYLOCOCCAL INFECTIONS; TISSUE DISTRIBUTION;

EID: 84963976702     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.115.161265     Document Type: Article

References (27)

1. 68Ga-labelled peptides in PET imaging of infection. Nucl Med Commun. 2008;29:663-665.
2. Gemmel F, Dumarey N, Welling M. Future diagnostic agents. Semin Nucl Med. 2009;39:11-26.
3. Welling MM, Lupetti A, Balter HS, et al. 99mTc-labelled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med. 2001;42:788-794.
4. Welling MM, Paulusma-Annema A, Balter HS, Pauwels EK, Nibbering PH. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med. 2000;27:292-301.
5. Nibbering PH, Welling MM, Paulusma-Annema A, Brouwer CP, Lupetti A, Pauwels EKJ. 99mTc-labelled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med. 2004;45:321-326.
6. Brouwer CP, Bogaards SJ, Wulferink M, Velders MP, Welling MM. Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice. Peptides. 2006;27:2585-2591.
7. Ferro-Flores G, Arteaga De Murphy C, Pedraza-López M, et al. In vitro and in vivo assessment of 99mTc-UBI specificity for bacteria. Nucl Med Biol. 2003;30: 597-603.
8. 68Galabelled peptides. Eur J Nucl Med Mol Imaging. 2012;39(suppl 1):S31-S40.
9. Morphy JR, Parker D, Alexander R, et al. Antibody labelling with functionalised cyclam macrocycles. J Chem Soc Chem Commun. 1988;3:156-158.
10. Craig AS, Parker D, Adams H, Bailey NA. Stability, 71Ga NMR, and crystal structure of a neutral gallium(III) complex of 1,4,7-triazacyclononanetriacetate: a potential radiopharmaceutical? J Chem Soc Chem Commun. 1989;23:1793-1794.
11. 68Ga) and (111In) for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors. Bioconjug Chem. 2002;13:530-541.
12. Lewis MR, Raubitschek A, Shively JE. A facile, water-soluble method for modification of proteins with DOTA: use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabeled immunoconjugates. Bioconjug Chem. 1994;5:565-576.
13. 68Ga-labelled peptides and oligonucleotides [thesis]. Uppsala, Sweden: Uppsala University; 2004.
14. Lupetti A, Nibbering PH, Welling MM, Pauwels E. Radiopharmaceuticals: new antimicrobial agents. Trends Biotechnol. 2003;21:70-73.
15. 68Ga. Eur J Nucl Med Mol Imaging. 2005; 32:478-485.
16. 68Ga-radiolabeling of NOTA-conjugated ubiquicidin fragments for prospective infection imaging with PET/CT. Nucl Med Biol. 2014;41:390-400.
17. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. Contrast Media Mol Imaging. 2008;3: 67-77.
18. 68Ga generator and aspects of radiolabelling DOTA-peptides. Appl Radiat Isot. 2011;69:308-315.
19. 68Ga with different bifunctional chelators. Nucl Med Biol. 2013;40:197-205.
20. Akhtar MS, Khan ME, Khan B, et al. An imaging analysis of 99mTc-UBI (29-41) uptake in S. aureus infected thighs of rabbits on ciprofloxacin treatment. Eur J Nucl Med Mol Imaging. 2008;35:1056-1064.
21. Welling MM, Mongera S, Lupetti A, et al. Radiochemical and biological characteristics of 99mTc-UBI 29-41 for imaging of bacterial infections. Nucl Med Biol. 2002;29:413-422.
22. Meléndez-Alafort L, Ramírez FDM, Ferro-Flores G, De Murphy CA, Pedraza-López M, Hnatowich DJ. Lys and Arg in UBI: a specific site for a stable Tc-99m complex? Nucl Med Biol. 2003;30:605-615.
23. 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging. J Nucl Med. 2014;55:308-314.
24. Meléndez-Alafort L, Rodríguez-Cortés J, Ferro-Flores G, et al. Biokinetics of 99mTc-UBI 29-41 in humans. Nucl Med Biol. 2004;31:373-379.
25. Akhtar MS, Qaisar A, Irfanullah J, et al. Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial. J Nucl Med. 2005;46: 567-573.
26. Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev. 2003;55:27-55.
27. Ferro-Flores G, Ramirez F, Melendez-Alafort L, Arteaga de Murphy C, Pedraza-Lopez M. Molecular recognition and stability of 99mTc-UBI 29-41 based on experimental and semiempirical results. Appl Radiat Isot. 2004;61: 1261-1268.